200 Participants Needed

3D Printed Models for Breast Cancer Surgery Planning

LC
Overseen ByLauren Chang Sen, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: M.D. Anderson Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on using 3D models for surgery planning, so it's unlikely to require changes to your medication.

What data supports the effectiveness of the treatment 3D printed models for breast cancer surgery planning?

Research shows that using 3D printed models for breast cancer surgery can help patients and doctors make better decisions about surgery options, improve understanding of the disease, and enhance communication, which can lead to better surgical outcomes.12345

Is it safe to use 3D printed models for breast cancer surgery planning?

The available research does not specifically address the safety of 3D printed models for breast cancer surgery planning, but these models are used to help patients and doctors understand the surgery better, which can improve decision-making and planning.12678

How does the 3D printed model treatment for breast cancer surgery planning differ from other treatments?

The 3D printed model treatment for breast cancer surgery planning is unique because it uses personalized, three-dimensional models to help patients and surgeons visualize the tumor and surrounding anatomy, improving decision-making and surgical planning. This approach enhances patient understanding and communication with the healthcare team, potentially leading to better surgical outcomes and reduced decision conflict compared to traditional methods that rely solely on imaging reports.12349

What is the purpose of this trial?

To learn if providing a 3-D printed model of the breast can help breast cancer patients make decisions related to their care. During this study, some study participants will receive the 3-D printed model and some study participants will receive traditional breast imaging scans to learn if the 3-D printed model

Research Team

LC

Lauren Chang Sen, MD

Principal Investigator

M.D. Anderson Cancer Center

Eligibility Criteria

This trial is for English-speaking women aged 18 or older with confirmed breast cancer, who are candidates for surgery and have had a breast MRI at MDACC. They must be willing to potentially receive either a 3D printed model of their breast or traditional imaging scans and consent to the study's process.

Inclusion Criteria

Patient is able to speak, read or write English
Patient is willing to be randomized to the control or 3D printed breast model groups and is willing to sign the consent form.
I am a woman aged 18 or older.
See 4 more

Exclusion Criteria

I had a mastectomy and my cancer has come back on the same side.
Pregnant and breastfeeding patients
It's not possible to make a 3D printed model of your breast using a breast MRI.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Consultation

Participants receive either a 3D printed model or traditional imaging during their surgical consultation

1 visit
1 visit (in-person)

Surgical Decision-making

Participants make decisions regarding their surgical options (mastectomy vs. lumpectomy) after viewing the models or imaging

2-4 weeks

Follow-up

Participants are monitored for satisfaction, well-being, and surgical outcomes post-surgery

1 year

Treatment Details

Interventions

  • 3D printed model
Trial Overview The study is testing whether providing patients with a 3D printed model of their breast helps in making decisions about their care compared to those who only receive traditional imaging scans. Participants will be randomly assigned to one of these two groups.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm 1: 3D printed modelExperimental Treatment1 Intervention
a 3-D printed model of your breast will be created and discussed with participants during your surgical consultation.
Group II: Arm 2: No 3D printed modelActive Control1 Intervention
Participants will have a standard-of-care surgical consultation using traditional breast imaging.

Find a Clinic Near You

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials
3,107
Recruited
1,813,000+

University Cancer Foundation via the Institutional Research Grant program at the University of Texas MD Anderson Cancer Center

Collaborator

Trials
1
Recruited
200+

Findings from Research

Creating a patient-specific 3D printed model of a breast cancer patient helped in visualizing the extent of the disease, which initially suggested a mastectomy was necessary.
Ultimately, the 3D model facilitated a decision for breast-conserving surgery, indicating that such models can improve patient understanding and potentially lead to better surgical outcomes.
The role of three-dimensional printing in the surgical management of breast cancer.Santiago, L., Adrada, BE., Caudle, AS., et al.[2020]
3D printed breast tumor models can significantly enhance patient understanding of their breast cancer diagnosis and treatment options, leading to better communication with healthcare teams.
These models not only aid in personalized treatment planning by visualizing patient-specific pathology but also serve as valuable educational tools for medical trainees involved in breast cancer care.
3D printed model for triple negative inflammatory breast cancer.Huang, YH., Tuttle, TM., Hoven, N.[2022]
In a case series involving five patients, 3D printing of breast cancer tumors was successfully achieved using data from MRI, digital breast tomosynthesis, and 3D ultrasound, demonstrating the feasibility of this technology in clinical practice.
The tumor volumes calculated from different imaging methods were comparable, suggesting that 3D printed models can accurately represent the spatial characteristics of tumors, which may aid surgeons in planning treatment strategies.
Semi-automated delineation of breast cancer tumors and subsequent materialization using three-dimensional printing (rapid prototyping).Schulz-Wendtland, R., Harz, M., Meier-Meitinger, M., et al.[2017]

References

The role of three-dimensional printing in the surgical management of breast cancer. [2020]
3D printed model for triple negative inflammatory breast cancer. [2022]
Semi-automated delineation of breast cancer tumors and subsequent materialization using three-dimensional printing (rapid prototyping). [2017]
Design and Fabrication of Three-Dimensional Printed Scaffolds for Cancer Precision Medicine. [2021]
Using 3D models in orthopedic oncology: presenting personalized advantages in surgical planning and intraoperative outcomes. [2020]
The impact of using three-dimensional printed liver models for patient education. [2020]
Cost-Benefit Analysis of Three-Dimensional Craniofacial Models for Midfacial Distraction: A Pilot Study. [2022]
Bioprinting and Differentiation of Adipose-Derived Stromal Cell Spheroids for a 3D Breast Cancer-Adipose Tissue Model. [2021]
Improved Surgery Planning Using 3-D Printing: a Case Study. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity